5-Year Colonoscopy Surveillance Noninferior to 3-Year After High-Risk Adenoma
An interim analysis of an ongoing 10-year noninferiority trial across eight European countries randomized 10,799 patients with high-risk adenomas to first surveillance colonoscopy at 5 years or 3 years after polyp removal. The trial reported a 5-year cumulative colorectal cancer incidence of 0.77% in the 5-year group versus 0.82% in the 3-year group, meeting the prespecified noninferiority criterion, with no substantial difference in cancer stage distribution or colorectal cancer deaths between groups. The authors note this is an interim analysis, with final results planned at 10 years.
Most relevant for: Patients who have undergone removal of high-risk adenomas (defined as adenomas ≥10 mm, high-grade dysplasia, villous growth, or 3 to 10 adenomas of any kind) and are due for surveillance colonoscopy.
Read the original at New England Journal of MedicineSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More family medicine updates
- Long-Acting Injectable HIV Therapy Noninferior for Adherence ChallengesOct 15, 2026
- 8-week sofosbuvir-velpatasvir regimen non-inferior to 12 weeks for HCVSep 30, 2026
- Lean MASLD shows milder histology but similar mortality outcomesSep 30, 2026
- Oral GLP-1 orforglipron shows cardiovascular non-inferiority to insulin glargineSep 30, 2026
- Retatrutide produces substantial weight loss in phase 3 diabetes trialSep 29, 2026